Aspects of achondroplasia in the skulls of dwarf transgenic mice: A cephalometric study

Anatomical Record - Part A Discoveries in Molecular, Cellular, and Evolutionary Biology

Volumn 288, Issue 3, 2006, Pages 316-322

  Bloom, Melissa Wadler ^a   Murakami, Shunichi ^b   Cody, Dianna ^c   Montufar Solis, Dina ^a   Duke, Pauline Jackie ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Achondroplasia; Cephalometrics; Dwarfism; FGFR3; Micro CT scan

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 3; MITOGEN ACTIVATED PROTEIN KINASE;

ACHONDROPLASIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE GROWTH; BONE RADIOGRAPHY; CELL DIFFERENTIATION; CEPHALOMETRY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DWARFISM; FORAMEN MAGNUM; GROWTH REGULATION; MIDFACE HYPOPLASIA; MOUSE; NASAL BONE; NONHUMAN; PRIORITY JOURNAL; PROGNATHIA; SINGLE NUCLEOTIDE POLYMORPHISM; SKULL; TRANSGENIC MOUSE;

ACHONDROPLASIA; ANIMALS; CEPHALOMETRY; DISEASE MODELS, ANIMAL; MICE; MICE, TRANSGENIC; SKULL;

ANIMALIA; MUS MUSCULUS;

EID: 33645024881     PISSN: 0003276X     EISSN: 15524892     Source Type: Journal    
DOI: 10.1002/ar.a.20308     Document Type: Article

References (22)

1. American Academy of Pediatrics Committee on Genetics. 1995. Health supervision for children with achondroplasia. Pediatrics 95:443-451.
2. Cohen MM Jr, Walker GF, Phillips C. 1985. A morphometric analysis of the craniofacial configuration in achondroplasia. J Craniofac Genet Dev Biol 1(Suppl):139-165.
3. Deng C, Wynshaw-Boris A, Zhou F, Kuo A, Leder P. 1996. Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell 84:911-921.
4. Duke PJ, Montufar-Solis D, Williams N, Kriswell D. 1996. Cephalometric changes in tail-suspended mice and the effect of a skeletal muscle transgene. Grav Space Biol Bull 10:58.
5. Engstrom H, Engstrom C, Hollender L, Magnusson BC, Thilander A. 1985. Effect of local irradiation on cranial skeletal growth sites in the rat. Prog Clin Biol Res 187:109-124.
6. Francomano CA, Ortiz de Luna RI, Hefferon TW, Bellus GA, Turner CE, Taylor E, Meyers DA, Blanton SH, Murray JC, McIntosh I, et al. 1994. Localization of the achondroplasia gene to the distal 2.5 Mb of human chromosome 4p. Hum Mol Genet 3:787-792.
7. Hecht JT, Horton WA, Reid CS, Pyeritz RE, Chakraborty R. 1989. Growth of the foramen magnum in achondroplasia. Am J Med Genet 32:528-535.
8. Hunter AG, Bankier A, Rogers JG, Sillence D, Scott CI Jr. 1998. Medical complications of achondroplasia: a multicentre patient review. J Med Genet 35:705-712.
9. Kahanovitz N, Rimoin D, Sillence D. 1982. The clinical spectrum of lumbar spine disease in achondroplasia. Spine 7:137-140.
10. Murakami S, Balmes G, McKinney S, Zhang Z, Givol D, de Crombrugghe B. 2004. Constitutive activation of MEK1 in chondrocytes causes a Stat1-independent achondroplasia-like dwarfism and rescues the Fgfr3-deficient Mice. Genes Dev 18:290-305.
11. Naski MC, Colvin JS, Coffin JD, Ornitz DM. 1998. Repression of hedgehog signaling and BMP4 expression in growth plate cartilage by fibroblast growth factor receptor 3. Development 125:4977-4988.
12. Oberklaid F, Danks DM, Jensen F, Stace L, Rosshandler S. 1979. Achondroplasia and hypochondroplasia: comments on frequency, mutation rate, and radiological features in skull and spine. J Med Genet 16:140-146.
13. Pauli RM, Scott CI, Wassman ER, Gilbert EF, Leavitt LA, Ver Hoeve J, Hall JG, Partington MW, Jones KL, Sommer A, et al. 1984. Apnea and sudden unexplained death in infants with achondroplasia. J Pediatr 104:342-348.
14. Sahni M, Ambrosetti DC, Mansukhani A, Gertner R, Levy D, Basilico C. 1999. FGF signaling inhibits chondrocyte proliferation and regulates bone development through the STAT-1 pathway. Genes Dev 13:1361-1366.
15. Schmidt-Nielsen K. 1984. Scaling why is animal size so important? New York: Cambridge University Press.
16. Segev O, Chumakov I, Nevo Z, Givol D, Madar-Shapiro L, Sheinin Y, Weinreb M, Yayon A. 2000. Restrained chondrocyte proliferation and maturation with abnormal growth plate vascularization and ossification in human FGFR-3(G380R) transgenic mice. Hum Mol Genet 9:249-258.
17. Spranger J. 1988. Bone dysplasia "families." Pathol Immunopathol R 7:76-80.
18. Su WC, Kitagawa M, Xue N, Xie B, Garofalo S, Cho J, Deng C, Horten WA, Fu XY. 1997. Activation of Stat1 by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism. Nature 386:288-292.
19. Vajo Z, Francomano CA, Wilkin DJ. 2000. The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: the achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans. Endocr Rev 21:23-39.
20. Wadler M, Williams N, Montufar-Solis D, Duke PJ. 2000. A transgene for muscle hypertrophy alters skeletal growth. J Dent Res 79:327.
21. Wang Y, Spatz MK, Kannan K, Hayk H, Avivi A, Gorivodsky M, Pines M, Yayon A, Lonai P, Givol D. 1999. A mouse model for achondroplasia produced by targeting fibroblast growth factor receptor 3. Proc Natl Acad Sci USA 96:4455-4460.
22. Wilkin DJ, Szabo JK, Cameron R, Henderson S, Bellus GA, Mack ML, Kaitila I, Loughlin J, Munnich A, Sykes B, Bonaventure J, Francomano CA. 1998. Mutations in fibroblast growth-factor receptor 3 in sporadic cases of achondroplasia occur exclusively on the paternally derived chromosome. Am J Hum Genet 63:711-716.